Fibrinolytic therapy in hospitals without percutaneous coronary intervention capabilities in China from 2001 to 2011: China PEACE-retrospective AMI study-Reference-Cited by-同舟云学术

Fibrinolytic therapy in hospitals without percutaneous coronary intervention capabilities in China from 2001 to 2011: China PEACE-retrospective AMI study

Published:2016-01-19 Issue:3 Volume:6 Page:232-243
ISSN:2048-8726
Container-title:European Heart Journal: Acute Cardiovascular Care
language:en
Short-container-title:European Heart Journal: Acute Cardiovascular Care

Author:

Li Jing¹,Li Xi¹,Ross Joseph S²³⁴⁵,Wang Qing¹,Wang Yongfei²⁶,Desai Nihar R²⁶,Xu Xiao²⁷,Nuti Sudhakar V²,Masoudi Frederick A⁸,Spertus John A⁹,Krumholz Harlan M²⁴⁵⁶,Jiang Lixin¹,

Affiliation:

1. National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, People’s Republic of China

2. Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, USA

3. Section of General Internal Medicine, Yale School of Medicine, USA

4. The Robert Wood Johnson Foundation Clinical Scholars Program, Yale School of Medicine, USA

5. Department of Health Policy and Management, Yale School of Public Health, USA

6. Section of Cardiovascular Medicine, Yale School of Medicine, USA

7. Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, USA

8. Division of Cardiology, University of Colorado Anschutz Medical Campus, USA

9. Saint Luke’s Mid America Heart Institute/University of Missouri-Kansas City, USA

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/2048872615626656

Reference33 articles.

1. ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data

2. Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries

3. Fibrinolysis or Primary PCI in ST-Segment Elevation Myocardial Infarction

4. Management of acute coronary syndromes in developing countries: ACute Coronary Events—a multinational Survey of current management Strategies

5. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genome-wide analysis identifies novel susceptibility loci for heart failure and nonischemic cardiomyopathy subtype;2024-08-02

2. Long-Term Prognosis of Different Reperfusion Strategies for ST-Segment Elevation Myocardial Infarction in Chinese County-Level Hospitals: Insight from China Acute Myocardial Infarction Registry;BIOMED ENVIRON SCI;2023

3. Changes in process and outcome for ST elevation myocardial infarction in central China from 2011 to 2018;Chinese Medical Journal;2023-08-04

4. Fibrinolytic therapy use for ST-segment elevation myocardial infarction and long-term outcomes in China: 2-year results from the China Acute Myocardial Infarction Registry;BMC Cardiovascular Disorders;2023-02-22

5. Using real world evidence to generate cost-effectiveness analysis of fibrinolytic therapy in patients with ST-segment elevation myocardial infarction in Thailand;LANCET REG HEALTH-W;2022